drugset / Trial / NCT01186263

Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy

NCT01186263 ↗

Phase 2 Completed 24 enrolled University of Magdeburg Sirtex Medical · collab
RandomizedParallel-groupSingle-blindDiagnostic

Summary

The purpose of this study is to assess the predictive value of 99mTechnetium (Tc)- labeled albumin in macroaggregates (MAA) and in microspheres (B20) injected into the common hepatic artery for the distribution of 90Yttrium- Selective Internal Radiotherapy (SIRT)-spheres (SIR- spheres).

Timeline

Start
2010-07
Primary completion
2011-07
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject B20 Diagnostic / imaging agent 5 ml Other
Subject B20 Diagnostic / imaging agent 150 mbq Other
Subject MAA Diagnostic / imaging agent 5 ml Other
Subject MAA Diagnostic / imaging agent 150 mbq Other